MedscapeStem Cell Therapy Shows Promise for Retinal DegenerationMedscapeNEW ORLEANS — Retinal pigment epithelial (RPE) cells derived from human embryonic stem cells can be safely transplanted into the eyes of patients with retinal degeneration, with ea… Continue reading
New York TimesFDA Speeds Review of Gene Therapies, Vowing to Target Rogue ClinicsNew York TimesThe Food and Drug Administration on Thursday issued new guidelines to speed the introduction of treatments involving human cells and tissues, including gene … Continue reading
New York TimesFDA Speeds Review of Gene Therapies, Vowing to Target Rogue ClinicsNew York TimesThe Food and Drug Administration on Thursday issued new guidelines to speed the introduction of treatments involving human cells and tissues, including gene … Continue reading
SFGateUS sets rules on stem cell therapies – SFGateSFGateThe U.S. Food and Drug Administration unveiled long-anticipated guidelines about stem-cell therapies Thursday that are meant to clear up confusion about …Stem Cell Therapy Shows Promise fo… Continue reading
San Francisco ChronicleUS sets rules on stem cell therapiesSan Francisco ChronicleThe U.S. Food and Drug Administration unveiled long-anticipated guidelines about stem-cell therapies Thursday that are meant to clear up confusion about which treatments … Continue reading
San Francisco ChronicleUS sets rules on stem cell therapiesSan Francisco ChronicleThe U.S. Food and Drug Administration unveiled long-anticipated guidelines about stem-cell therapies Thursday that are meant to clear up confusion about which treatments … Continue reading
FDA Grants BCMA CAR T-Cell Therapy Breakthrough Designation in MyelomaOncLiveThe FDA has granted bb2121 a breakthrough therapy designation for previously treated patients with relapsed/refractory multiple myeloma, according to Celgene Corporation and b… Continue reading
|
North Dakota stem cell clinic investigated after complaints
Albany Times Union BISMARCK, N.D. (AP) — The North Dakota Attorney General’s office is investigating a Bismarck stem cell clinic amid complaints that it provided improper information to patients about the benefits and costs of its services. The subject of the formal … |